Prothena | PRTA - Kewajiban Lancar





Kewajiban Lancar Perubahan Tanggal
Acadia Pharmaceuticals USD 277.11M 79.47M 2025-12
Agios Pharmaceuticals USD 58.84M 23.36M 2026-03
Akebia Therapeutics USD 162.94M 29.56M 2025-12
ALKERMES USD 599.5M 56.06M 2026-03
Alnylam Pharmaceuticals USD 1.35B 116.87M 2026-03
Amgen USD 24.96B 534M 2026-03
Biogen USD 3B 350.5M 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Exelixis USD 405.64M 31.86M 2025-12
Immunic USD 30.62M 539K 2025-12
Incyte USD 1.49B 25.52M 2026-03
Ionis Pharmaceuticals USD 717M 66M 2026-03
MacroGenics USD 43.11M 1.36M 2025-12
Nektar Therapeutics USD 53.54M 12.8M 2025-12
Neurocrine Biosciences USD 831.7M 88.3M 2026-03
Prothena USD 40.84M 10.59M 2025-12
Regeneron Pharmaceuticals USD 5.11B 739.3M 2026-03
Ultragenyx Pharmaceutical USD 384M 43.98M 2025-12
Vertex Pharmaceuticals USD 3.88B 19.4M 2026-03
Xoma USD 28.3M 6.81M 2025-09